The agreement for Novartis to buy Alcon from Nestlé has...

The agreement for Novartis to buy Alcon from Nestlé has completed its first step, with Novartis paying about $10.4 billion for 74 million shares of Alcon, or just under 25 percent of the company's common stock. At this point, Nestlé retains majority ownership with about 52 percent. However, Novartis has ...

Keep reading this article by becoming a member

barrier_image_OIC

Enjoy unrestricted access to Eyewear Intelligence

To continue reading this article subscribe now

  • Unlimited access to our highly trusted industry insights and analysis
  • Benchmark yourself against the market and competitors
  • Find inspiration to drive your business forward
  • Stay up to date with new business models and startups

If you aren’t ready to subscribe now, you can REGISTER FOR FREE. Already an Eyewear Intelligence subscriber? Sign in here.